Evidence map›Paper›PMID 35171365›Full record

ArticleClinical rheumatology2022

Altered levels of circulating CD8

Xuwen Zhai, Yanlin Wang, Hui Guo, Zhaojun Liang, Min Feng, Yanyao Wu, Yan Qin, Xiangcong Zhao, Chong Gao, Jing Luo

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. An angel or a devil? Current view on the role of CD8Journal of translational medicine · 2024
    Review
  5. Review
  6. Article
  7. Review
  8. CD4Frontiers in immunology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Xuwen Zhai *The Clinical Skills Teaching, Simulation Hospital of Shanxi Medical University, Jinzhong, 030600, Shanxi, China.
Yanlin Wang *Division of Rheumatology, Department of Medicine, The Second Hospital of Shanxi Medical University, Taiyuan, 030001, Shanxi, China.
Hui Guo *Division of Nephrology, Department of Medicine, The Second Hospital of Shanxi Medical University, Taiyuan, 030001, Shanxi, China.
Zhaojun LiangDivision of Rheumatology, Department of Medicine, The Second Hospital of Shanxi Medical University, Taiyuan, 030001, Shanxi, China.
Min FengDivision of Rheumatology, Department of Medicine, The Second Hospital of Shanxi Medical University, Taiyuan, 030001, Shanxi, China.
Yanyao WuDivision of Rheumatology, Department of Medicine, The Second Hospital of Shanxi Medical University, Taiyuan, 030001, Shanxi, China.
Yan QinDivision of Rheumatology, Department of Medicine, The Second Hospital of Shanxi Medical University, Taiyuan, 030001, Shanxi, China.
Xiangcong ZhaoDivision of Rheumatology, Department of Medicine, The Second Hospital of Shanxi Medical University, Taiyuan, 030001, Shanxi, China.
Chong GaoDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Jing LuoDivision of Rheumatology, Department of Medicine, The Second Hospital of Shanxi Medical University, Taiyuan, 030001, Shanxi, China. ljty966@hotmail.com.ORCID http://orcid.org/0000-0002-1242-0286
Shanxi Medical University · CNBrigham and Women's Hospital · US

Funding

Science and Technology Innovation Project of Shanxi Province 2020SYS08The Nature Fund Projects of Shanxi Science and Technology Department 201901D111377The Research Project Supported by Shanxi Scholarship Council of China 2020-191The Scientific Research Project of Health commission of Shanxi Province 2019044
6 · The paper itself

Abstract

backgroundCirculating CD8

methodsCirculating CD8

resultsThe proportions and numbers of CD8

conclusionsWe identified a new CD8

Indexed as

Sjogren's SyndromeCD8-Positive T-LymphocytesHumansProgrammed Cell Death 1 ReceptorReceptors, CXCR5T-Lymphocytes, RegulatoryT-Lymphocyte SubsetsCXCR5 protein, humanProgrammed Cell Death 1 ReceptorReceptors, CXCR5CD8+CXCR5+ follicular cytotoxic T subsetsCD8+ regulatory T cellsLung involvementOPLS-DAPrimary Sjögren’s syndrome

Identifiers

PMID35171365
OpenAlexW4213370136

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.